The Two Faces of Relaxin in Cancer: Antitumor or Protumor?
Hepatology
.
2020 Mar;71(3):1117-1119.
doi: 10.1002/hep.30998.
Authors
Sumera Rizvi
1
,
Gregory J Gores
1
Affiliation
1
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
PMID:
31630431
PMCID:
PMC7089805
DOI:
10.1002/hep.30998
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Liver Neoplasms*
Relaxin*
Xenograft Model Antitumor Assays
Substances
Relaxin
Grants and funding
K08 CA236874/CA/NCI NIH HHS/United States
P50 CA210964/CA/NCI NIH HHS/United States